Gaudium IVF and Women Health Limited Financial Ratios
GAUDIUMIVF · Healthcare · Current price ₹101.7
P/E ratio
30.3x
P/B ratio
5.5x
ROE
16.1%
ROCE
20.2%
Debt / Equity
0.16
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 30.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 20.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.16 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Gaudium IVF and Women Health Limited's latest numbers.
Gaudium IVF and Women Health Limited profitability
Gaudium IVF and Women Health Limited generates a return on equity of 16.1% and a return on capital employed of 20.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.16 and a P/E of 30.3x, Gaudium IVF and Women Health Limited is conservatively financed. Our overall business-quality score for the company is 6.3 / 10.
Understand the ratios
More on Gaudium IVF and Women Health Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.